Neurocognitive Effects of Chemotherapy for Colorectal Cancer: A Systematic Review and a Meta-Analysis of 11 Studies

키워드

참고문헌 (51)

1. Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
2. van Dam FS, "Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer : high-dose versus standard-dose chemotherapy", J Natl Cancer Inst, 90, pp.210~218 (1998)
3. Anderson-Hanley C, "Neuropsychological effects of treatments for adults with cancer : a meta-analysis and review of the literature", J Int Neuropsychol Soc, 9, pp.967~982 (2003)
4. Cruzado JA, "Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients", Support Care Cancer, 22, pp.1815~1823 (2014)
5. Vardy JL, "Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy : a prospective, longitudinal, controlled study", J Clin Oncol, 33, pp.4085~4092 (2015)
6. Seigers R, "Neurobiological basis of chemotherapyinduced cognitive impairment : a review of rodent research", Neurosci Biobehav Rev, 35, pp.729~741 (2011)
7. Branca JJ, "Oxaliplatin-induced blood brain barrier loosening : a new point of view on chemotherapy-induced neurotoxicity", Oncotarget, 9, pp.23426~23438 (2018)
8. Wigmore PM, "Effects of 5-FU", Adv Exp Med Biol, 678, pp.157~164 (2010)
9. Vardy JL, "Cancer-induced cognitive impairment : practical solutions to reduce and manage the challenge", Future Oncol, 13, pp.767~771 (2017)
10. Fernandes HA, "Cognitive rehabilitation for cancer-related cognitive dysfunction : a systematic review", Support Care Cancer, 27, pp.3253~3279 (2019)
11. Ahles TA, "Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer : impact of age and cognitive reserve", J Clin Oncol, 28, pp.4434~4440 (2010)
12. Bleecker ML, "Impact of cognitive reserve on the relationship of lead exposure and neurobehavioral performance", Neurology, 69, pp.470~476 (2007)
13. Anstey KJ, "Selfreported history of chemotherapy and cognitive decline in adults aged 60 and older : the PATH Through Life Project", J Gerontol A Biol Sci Med Sci, 70, pp.729~735 (2015)
14. Lee SH, "Quality of life changes during adjuvant chemotherapy in patients with colon cancer", Korean J Clin Oncol, 12, pp.60~66 (2016)
15. Andreis F, "Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients : a pilot study", Support Care Cancer, 21, pp.583~590 (2013)
16. Sales MV, "Effects of adjuvant chemotherapy on cognitive function of patients eith rarly-stage volorectal vancer", Clin Colorectal Cancer, 18, pp.19~27 (2019)
17. Mayrbaurl B, "Quality of life across chemotherapy lines in patients with advanced colorectal cancer : a prospective single-center observational study", Support Care Cancer, 24, pp.667~674 (2016)
18. Tsunoda A, "Health-related quality of life in patients with colorectal cancer who receive oral uracil and tegafur plus leucovorin", Jpn J Clin Oncol, 40, pp.412~419 (2010)
19. Couwenberg AM, "Effect of neoadjuvant therapy and rectal surgery on health-related quality of life in patients with rectal cancer during the first 2 years after diagnosis", Clin Colorectal Cancer, 17, pp.e499~512 (2018)
20. Souza J, "Health-related quality of life assessment in patients with rectal cancer treated with curative intent", Arq Gastroenterol, 55, pp.154~159 (2018)
21. Bencova V, "Indication of pre-surgical radiochemotherapy enhances psychosocial morbidity among patients with resectable locally advanced rectal cancer", Neoplasma, 63, pp.635~641 (2016)
22. Horowitz TS, "Understanding the profile of cancer-related cognitive impairments : a critique of meta-analyses", J Natl Cancer Inst, 111, pp.1009~1015 (2019)
23. Fayers P, "EORTC QLQ-C30 scoring manual" (2001), European Organisation for Research and Treatment of Cancer
24. Higgins JP, "Measuring inconsistency in meta-analyses", BMJ, 327, pp.557~560 (2003)
25. "The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses" (2021)[URL]
26. Luchini C, "Assessing the quality of studies in meta-analyses : advantages and limitations of the Newcastle Ottawa Scale", World J Meta-Anal, 5, pp.80~84 (2017)
27. Faraone SV, "Interpreting estimates of treatment effects : implications for managed care", P T, 33, pp.700~711 (2008)
28. Hodgson KD, "A meta-analysis of the effects of chemotherapy on cognition in patients with cancer", Cancer Treat Rev, 39, pp.297~304 (2013)
29. Bernstein LJ, "Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed : a multilevel meta-analysis", Neurosci Biobehav Rev, 83, pp.417~428 (2017)
30. Jansen CE, "A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function", Cancer, 104, pp.2222~2233 (2005)
31. Falleti MG, "The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer : a metaanalysis of the current literature", Brain Cogn, 59, pp.60~70 (2005)
32. Stewart A, "A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer", Clin Neuropsychol, 20, pp.76~89 (2006)
33. Ono M, "A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer", Front Oncol, 5, pp.59~ (2015)
34. Jim HS, "Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy", J Clin Oncol, 30, pp.3578~3587 (2012)
35. Lindner OC, "A meta-analysis of cognitive impairment following adult cancer chemotherapy", Neuropsychology, 28, pp.726~740 (2014)
36. Bartels C, "Practice effects in healthy adults : a longitudinal study on frequent repetitive cognitive testing", BMC Neurosci, 11, pp.118~ (2010)
37. Lezak MD, "Neuropsychological assessment" (2004), Oxford University Press
38. McCaffrey RJ, "Practitioner’s guide to evaluating change with neuropsychological assessment instruments" (2000), Springer Science & Business Media
39. McCaffrey RJ, "Issues associated with repeated neuropsychological assessments", Neuropsychol Rev, 5, pp.203~221 (1995)
40. Dodge HH, "Cohort effects in age-associated cognitive trajectories", J Gerontol A Biol Sci Med Sci, 69, pp.687~694 (2014)
41. Dodge HH, "Cohort effects in verbal memory function and practice effects : a population-based study", Int Psychogeriatr, 29, pp.137~148 (2017)
42. Wefel JS, "International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer", Lancet Oncol, 12, pp.703~708 (2011)
43. Pendergrass JC, "Cognitive impairment associated with cancer : a brief review", Innov Clin Neurosci, 15, pp.36~44 (2018)
44. Hardy SJ, "Cognitive changes in cancer survivors", Am Soc Clin Oncol Educ Book, 38, pp.795~806 (2018)
45. Anampa J, "Progress in adjuvant chemotherapy for breast cancer : an overview", BMC Med, 13, pp.195~ (2015)
46. Bianchi E, "Apoptotic process induced by oxaliplatin in rat hippocampus causes memory impairment", Basic Clin Pharmacol Toxicol, 120, pp.14~21 (2017)
47. Fardell JE, "Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity", Psychopharmacology(Berl), 220, pp.183~193 (2012)
48. Vega JN, "Cognitive effects of chemotherapy and cancer-related treatments in older adults", Am J Geriatr Psychiatry, 25, pp.1415~1426 (2017)
49. Maccormick RE, "Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty?", Med Hypotheses, 67, pp.212~215 (2006)
50. Ahles TA, "Candidate mechanisms for chemotherapy-induced cognitive changes", Nat Rev Cancer, 7, pp.192~201 (2007)
51. Dikmen SS, "Test-retest reliability and practice effects of expanded Halstead-Reitan Neuropsychological Test Battery", J Int Neuropsychol Soc, 5, pp.346~356 (1999)

관련 논문AI추천